Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($2.74) EPS for the quarter, missing the consensus estimate of ($1.71) by ($1.03), Zacks reports.
Cadrenal Therapeutics Price Performance
Shares of NASDAQ:CVKD opened at $19.09 on Friday. The firm has a market capitalization of $34.04 million, a PE ratio of -2.86 and a beta of 1.40. The business has a 50-day moving average of $18.31 and a two-hundred day moving average of $15.03. Cadrenal Therapeutics has a 12 month low of $5.40 and a 12 month high of $22.90.
About Cadrenal Therapeutics
Read More
- Five stocks we like better than Cadrenal Therapeutics
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- What is Short Interest? How to Use It
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
- What Are the FAANG Stocks and Are They Good Investments?
- Why Costco Stock Is Poised to Hit $1,000 Again Soon
Receive News & Ratings for Cadrenal Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cadrenal Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.